NSW emergency visits tied to unapproved peptides rise from 5 to 220 monthly
NSW Health counted 1,180 presentations between July 2025 and September 2026, naming BPC-157, GHK-Cu, TB-500, retatrutide and CJC-1295 in unapproved products.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 18 17:31 ETSource: Australian Broadcasting Corporation
The wire
- 01NSW Health data show 1,180 people presented to New South Wales emergency departments from July 2025 through September 2026 after taking unapproved peptides, with monthly visits climbing from 5 in July 2025 to nearly 220 last month.
- 02Health Minister Ryan Park cited liver and kidney damage, allergic reactions and severe vomiting, and said people should use only TGA-approved peptide products prescribed by a doctor and dispensed by a pharmacy.
- 03Park said the issue will likely go to health ministers in coming months; the data do not break down which products or doses were involved in individual presentations.
From the source
Read at abc.net.au'Very dangerous' unapproved peptide explosion hits NSW hospitals - ABC News & Headlines
Hospital visits related to the use of unapproved peptide use has surged in NSW, authorities say. ( ABC News )
